Mirum Pharmaceuticals, Inc. develops and delivers treatments for rare diseases, focusing on conditions with significant unmet medical needs. The company operates a pipeline of investigational medicines and has several approved products, emphasizing regulatory strategy, patient access, and real-world implementation. Mirum's activities are driven by collaboration with patients and families, aiming to provide meaningful therapies for small, high-need populations globally.
